When will diabetics in the U.S. get a bloodless glucometer that will allow them to check their blood sugar without a finger prick? The short answer is, we don’t know for sure. But a company that’s wrapped up initial testing of its bloodless glucometer and closed a series B round of financing thinks it has a good shot at becoming the “first noninvasive technology with a real shot at diagnostic accuracy,” in the words of its CEO.
